Insmed | INSM - Despesa De Juros Sobre A Dívida





Despesa De Juros Sobre A Dívida Alterar Data
BioMarin Pharmaceutical USD 63.29M 48.34M 2026-06
Cytokinetics USD 34.83M 1.5M 2026-06
DBV Technologies USD 461K 323.71K 2025-03
Gilead Sciences USD 247M 7M 2026-06
Heron Therapeutics USD 600K 100K 2024-12
Insmed USD 18.84M 1.24M 2026-06
Novartis USD 281M 8M 2025-09
Regeneron Pharmaceuticals USD 11M 1.9M 2026-06
Sarepta Therapeutics USD 21.51M 205K 2026-06
Ultragenyx Pharmaceutical USD 22M 1000K 2026-06
Vertex Pharmaceuticals USD 3.3M 0 2025-12